These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 20443679

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Large B-cell lymphoma with Hodgkin's features.
    García JF, Mollejo M, Fraga M, Forteza J, Muniesa JA, Pérez-Guillermo M, Pérez-Seoane C, Rivera T, Ortega P, Piris MA.
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [Abstract] [Full Text] [Related]

  • 23. Nodal Involvement by CD30+ Cutaneous Lymphoproliferative Disorders and Its Challenging Differentiation From Classical Hodgkin Lymphoma.
    Lezama LS, Gratzinger D.
    Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
    Kovrigina AM, Probatova NA.
    Arkh Patol; 2005 Jan; 67(4):10-6. PubMed ID: 16209291
    [Abstract] [Full Text] [Related]

  • 28. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
    Gorczyca W, Tsang P, Liu Z, Wu CD, Dong HY, Goldstein M, Cohen P, Gangi M, Weisberger J.
    Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
    [Abstract] [Full Text] [Related]

  • 29. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
    Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, Jaffe ES, Han J, van Krieken JM, Poppema S, Marafioti T, Franklin J, Sextro M, Diehl V, Stein H.
    Blood; 2000 Sep 01; 96(5):1889-99. PubMed ID: 10961891
    [Abstract] [Full Text] [Related]

  • 30. Variable expression of B-cell transcription factors in reactive immunoblastic proliferations: a potential mimic of classical Hodgkin lymphoma.
    Treetipsatit J, Rimzsa L, Grogan T, Warnke RA, Natkunam Y.
    Am J Surg Pathol; 2014 Dec 01; 38(12):1655-63. PubMed ID: 24921642
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. MMA monoclonal antibody is a superior anti-CD15 reagent for the diagnosis of classical Hodgkin's lymphoma?
    Pellegrini W, Bresciani G, De Zorzi A, Marocolo D, Ungari M, Facchetti F.
    Haematologica; 2007 May 01; 92(5):708-9. PubMed ID: 17488702
    [Abstract] [Full Text] [Related]

  • 34. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy.
    Falini B, Pileri S, Pizzolo G, Dürkop H, Flenghi L, Stirpe F, Martelli MF, Stein H.
    Blood; 1995 Jan 01; 85(1):1-14. PubMed ID: 7803786
    [No Abstract] [Full Text] [Related]

  • 35. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
    Salama ME, Rajan Mariappan M, Inamdar K, Tripp SR, Perkins SL.
    Int J Surg Pathol; 2010 Apr 01; 18(2):121-8. PubMed ID: 19223373
    [Abstract] [Full Text] [Related]

  • 36. Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
    Rentas Torres Y, Rodríguez-López JL, Valentin M, Silva H.
    Bol Asoc Med P R; 2015 Apr 01; 107(3):98-101. PubMed ID: 26742206
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
    Gharbaran R, Goy A, Tanaka T, Park J, Kim C, Hasan N, Vemulapalli S, Sarojini S, Tuluc M, Nalley K, Bhattacharyya P, Pecora A, Suh KS.
    J Hematol Oncol; 2013 Aug 29; 6():62. PubMed ID: 23988031
    [Abstract] [Full Text] [Related]

  • 40. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
    Moroch J, Copie-Bergman C, de Leval L, Plonquet A, Martin-Garcia N, Delfau-Larue MH, Molinier-Frenkel V, Belhadj K, Haioun C, Audouin J, Swerdlow SH, Marafioti T, Gaulard P.
    Am J Surg Pathol; 2012 Nov 29; 36(11):1636-46. PubMed ID: 23073322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.